Skip to main content

Rothblatt Martine A's Form 4 filing

United Therapeutics CorpUTHR · filed Oct 27, 2026

Accession no.
0001106578-26-000172
Filed
Oct 27, 2026, 4:30 PM ET
Trade date
Oct 26, 2026
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 9 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.59M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rothblatt Martine ACIK 0001106578Director, Officer (Chairperson & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 26, 2026Common StockMOption exerciseAcquired+9,500$117.76+$1,118,720333,943Indirect
Oct 26, 2026Common StockSSaleDisposed−600$585.71F3−$351,427.32333,343Indirect
Oct 26, 2026Common StockSSaleDisposed−1,492$586.54F4−$875,124.39331,851Indirect
Oct 26, 2026Common StockSSaleDisposed−2,707$587.54F5−$1,590,474.3329,144Indirect
Oct 26, 2026Common StockSSaleDisposed−1,241$588.47F6−$730,285.44327,903Indirect
Oct 26, 2026Common StockSSaleDisposed−1,280$589.64F7−$754,736.38326,623Indirect
Oct 26, 2026Common StockSSaleDisposed−680$590.57F8−$401,585.49325,943Indirect
Oct 26, 2026Common StockSSaleDisposed−694$591.60F9−$410,570.4325,249Indirect
Oct 26, 2026Common StockSSaleDisposed−806$592.92F10−$477,890.94324,443Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 26, 2026Common StockMOption exerciseDisposed−9,500$0.00$0157,410Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

This transaction was executed in multiple trades at prices ranging from $585.01 to $585.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $586.035 to $587.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F5

This transaction was executed in multiple trades at prices ranging from $587.04 to $588.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F6

This transaction was executed in multiple trades at prices ranging from $588.09 to $589.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F7

This transaction was executed in multiple trades at prices ranging from $589.10 to $590.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F8

This transaction was executed in multiple trades at prices ranging from $590.20 to $591.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F9

This transaction was executed in multiple trades at prices ranging from $591.36 to $592.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F10

This transaction was executed in multiple trades at prices ranging from $592.46 to $593.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)